体外膜肺氧合支持期间新发感染的研究进展

doi:10.3877/cma.j.issn.2096-1537.2024.03.014

近年来，体外膜肺氧合（ECMO）在急性可逆性心脏和（或）呼吸衰竭患者中应用越来越广泛。尽管ECMO的疗效已被证实，但它也有很多并发症，感染是ECMO期间常见并发症之一。ECMO期间感染可能影响ECMO患者的病死率。本文结合相关研究对ECMO支持期间新发感染进行综述以更深入地了解、预防和减少感染并发症。

关键词: 体外膜肺氧合, 体外生命支持, 感染, 并发症

In recent years, extracorporeal membrane oxygenation (ECMO) is being widely used to treat patients with acute reversibility refractory cardiogenic shock and/or refractory respiratory failure. Despite its proven efficacy, ECMO carries significant risks for complications, and infection is one of the most common complications during ECMO support. Infections during ECMO support have significantly increased mortality of these patients. In this paper, infections during ECMO support have been reviewed for a better understanding, prevention and management.

Key words: Extracorporeal membrane oxygenation, Extracorporeal life support, Infection, Complications

表1 单中心研究中ECMO支持期间感染参考定义和时间窗

文献作者及发表年份	定义	时间窗
Hsu等^[6]，2009	美国疾病控制和预防中心感控指南	ECMO启动后24 h至ECMO撤机后48 h
Burket等^[7]，1999	美国疾病控制和预防中心感控指南	ECMO启动后24 h至ECMO撤机后48 h
Schmidt等^[8]，2012	美国疾病控制和预防中心感控指南	ECMO启动后24 h至ECMO撤机后48 h
Ayyıldız等^[9]，2017	急症处置机构医疗保健相关感染的监测定义和特定类型感染的诊断标准	ECMO启动后24 h至ECMO撤机后48 h
Calderón等^[10]，2018	急症处置机构医疗保健相关感染的监测定义和特定类型感染的诊断标准	ECMO启动至ECMO撤离
Aubron等^[11]，2013	急症处置机构医疗保健相关感染的监测定义和特定类型感染的诊断标准	ECMO启动后48 h至ECMO撤机后72 h
Sun等^[12]，2010	美国疾病控制和预防中心感控指南	ECMO启动至ECMO撤离
Kim等^[13]，2017	美国疾病控制和预防中心感控指南	ECMO启动后48 h至ECMO撤机后24 h

表1 单中心研究中ECMO支持期间感染参考定义和时间窗

文献作者及发表年份	定义	时间窗
Hsu等^[6]，2009	美国疾病控制和预防中心感控指南	ECMO启动后24 h至ECMO撤机后48 h
Burket等^[7]，1999	美国疾病控制和预防中心感控指南	ECMO启动后24 h至ECMO撤机后48 h
Schmidt等^[8]，2012	美国疾病控制和预防中心感控指南	ECMO启动后24 h至ECMO撤机后48 h
Ayyıldız等^[9]，2017	急症处置机构医疗保健相关感染的监测定义和特定类型感染的诊断标准	ECMO启动后24 h至ECMO撤机后48 h
Calderón等^[10]，2018	急症处置机构医疗保健相关感染的监测定义和特定类型感染的诊断标准	ECMO启动至ECMO撤离
Aubron等^[11]，2013	急症处置机构医疗保健相关感染的监测定义和特定类型感染的诊断标准	ECMO启动后48 h至ECMO撤机后72 h
Sun等^[12]，2010	美国疾病控制和预防中心感控指南	ECMO启动至ECMO撤离
Kim等^[13]，2017	美国疾病控制和预防中心感控指南	ECMO启动后48 h至ECMO撤机后24 h

表2 单中心研究ECMO支持期间感染发生率统计

文献作者	研究群体	感染[例（%）]
Hsu等^[6]	114例成人	10（8.8）
Burket等^[7]	71例患者（年龄≥17岁）	32（45.1）
Schmidt等^[8]	220例成人	142（64.5）
Ayyıldız等^[9]	25例新生儿，37例婴儿，3例儿童，1例成人	28（42.4）
Calderón等^[10]	50例年龄0~16岁患者	20（40.0）
Aubron等^[11]	139例患者（年龄≥17岁）	36（25.9）
Sun等^[12]	334例患者（年龄≥16岁）	45（13.5）
Kim等^[13]	61例患者（年龄≥17岁）	14（23.0）
Cashen等^[21]	247例新生儿，114例婴儿，77例儿童，43例成人	80（16.6）
Tse-Chang等^[22]	117例儿童（包括新生儿）	35（29.9）
Castagnola等^[23]	45例患者（年龄1 d~31岁）	12（26.6）
Quintana等^[24]	288例成人	58（20.1）

表2 单中心研究ECMO支持期间感染发生率统计

文献作者	研究群体	感染[例（%）]
Hsu等^[6]	114例成人	10（8.8）
Burket等^[7]	71例患者（年龄≥17岁）	32（45.1）
Schmidt等^[8]	220例成人	142（64.5）
Ayyıldız等^[9]	25例新生儿，37例婴儿，3例儿童，1例成人	28（42.4）
Calderón等^[10]	50例年龄0~16岁患者	20（40.0）
Aubron等^[11]	139例患者（年龄≥17岁）	36（25.9）
Sun等^[12]	334例患者（年龄≥16岁）	45（13.5）
Kim等^[13]	61例患者（年龄≥17岁）	14（23.0）
Cashen等^[21]	247例新生儿，114例婴儿，77例儿童，43例成人	80（16.6）
Tse-Chang等^[22]	117例儿童（包括新生儿）	35（29.9）
Castagnola等^[23]	45例患者（年龄1 d~31岁）	12（26.6）
Quintana等^[24]	288例成人	58（20.1）

1	Marasco SF, Lukas G, McDonald M, et al. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients [J]. Heart Lung Circ, 2008, 17 (Suppl 4): 41-47.
2	Vogel AM, Lew DF, Kao LS, et al. Defining risk for infectious complications on extracorporeal life support [J]. J Pediatr Surg, 2011, 46(12): 2260-2264.
3	Bizzarro MJ, Conrad SA, Kaufman DA, et al. Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults [J]. Pediatr Crit Care Med, 2011, 12(3): 277-281.
4	Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections [J]. Am J Infect Control, 1988, 16(3): 128-140.
5	Tan VE, Moore WS, Chopra A, et al. Association of procalcitonin values and bacterial infections in pediatric patients receiving extracorporeal membrane oxygenation [J]. Perfusion, 2018, 33(4): 278-282.
6	Hsu MS, Chiu KM, Huang YT, et al. Risk factors for nosocomial infection during extracorporeal membrane oxygenation [J]. J Hosp Infect, 2009, 73(3): 210-216.
7	Burket JS, Bartlett RH, Vander HK, et al. Nosocomial infections in adult patients undergoing extracorporeal membrane oxygenation [J]. Clin Infect Dis, 1999, 28(4): 828-833.
8	Schmidt M, Brechot N, Hariri S, et al. Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation [J]. Clin Infect Dis, 2012, 55(12): 1633-1641.
9	Ayyɪldɪz P, Kasar T, Ozturk E, et al. The evaluation of nosocomial infections in pediatric patients with extracorporeal membrane oxygenation support [J]. Braz J Cardiovasc Surg, 2017, 32(6): 468-474.
10	Calderón Checa RM, Rojo Conejo P, González-Posada Flores AF, et al. Experience with infections in the use of extracorporeal membrane oxygenation [J]. Anales de Pediatría (Engl Ed), 2018, 89(2): 86-91.
11	Aubron C, Cheng AC, Pilcher D, et al. Infections acquired by adults who receive extracorporeal membrane oxygenation: risk factors and outcome [J]. Infect Control Hosp Epidemiol, 2013, 34(1): 24-30.
12	Sun HY, Ko WJ, Tsai PR, et al Infections occurring during extracorporeal membrane oxygenation use in adult patients [J]. J Thorac Cardiovasc Surg, 2010, 140(5): 1125-1132.
13	Kim GS, Lee KS, Park CK, et al. Nosocomial infection in adult patients undergoing veno-arterial extracorporeal membrane oxygenation [J]. J Korean Med Sci, 2017, 32(4): 593-598.
14	Winiszewski H, Boyadjian C, Besch G, et al. ECMO cannula-associated infections: interest of cannula swab and subcutaneous needle aspirate samples for prediction of cannula tip culture [J]. Intensive Care Med Exp, 2020, 8(1): 35.
15	Pieri M, Greco T, De Bonis M, et al. Diagnosis of infection in patients undergoing extracorporeal membrane oxygenation: a case-control study [J]. J Thorac Cardiovasc Surg, 2012, 143(6): 1411-1416.
16	Tanaka D, Pitcher HT, Cavarocchi NC, et al. Can procalcitonin differentiate infection from systemic inflammatory reaction in patients on extracorporeal membrane oxygenation? [J]. J Heart Lung Transplant, 2014, 33(11): 1186-1188.
17	Orszag P, Disque C, Keim S, et al. Monitoring of patients supported by extracorporeal membrane oxygenation for systemic infections by broad-range rRNA gene PCR amplification and sequence analysis [J]. J Clin Microbiol, 2013, 52(1): 307-311.
18	Biffi S, Di Bella S, Scaravilli V, et al. Infections during extracorporeal membrane oxygenation: epidemiology, risk factors, pathogenesis and prevention [J]. Int J Antimicrob Agents, 2017, 50(1): 9-16.
19	Meyer DM, Jessen ME, Eberhart RC. Neonatal extracorporeal membrane oxygenation complicated by sepsis. Extracorporeal Life Support Organization [J]. Ann Thorac Surg, 1995, 59(4): 975-980.
20	Douglass BH, Keenan AL, Purohit DM, et al. Bacterial and fungal infection in neonates undergoing venoarterial extracorporeal membrane oxygenation: an analysis of the registry data of the extracorporeal life support organization [J]. Artificial organs, 1996, 20(3): 202-208.
21	Cashen K, Reeder R, Dalton HJ, et al. Acquired infection during neonatal and pediatric extracorporeal membrane oxygenation [J]. Perfusion, 2018, 33(6): 472-482.
22	Tse-Chang A, Midodzi W, Joffe AR, et al. Infections in children receiving extracorporeal life support [J]. Infect Control Hosp Epidemiol, 2011, 32(2): 115-120.
23	Castagnola E, Gargiullo L, Loy A, et al. Epidemiology of infectious complications during extracorporeal membrane oxygenation in children: a single-center experience in 46 runs [J]. Pediatr Infect Dis J, 2018, 37(7): 624-626.
24	Quintana MT, Mazzeffi M, Galvagno SM, et al. A retrospective study of infection in patients requiring extracorporeal membrane oxygenation support [J]. Ann Thorac Surg, 2021, 112(4): 1168-1175.
25	O'Neill J, Schutze G, Heulitt MJ, et al. Nosocomial infections during extracorporeal membrane oxygenation [J]. Intensive Care Med, 2001, 27(8): 1247-1253.
26	Santiago-Lozano MJ, Barquín-Conde ML, Fuentes-Moreno L, et al. Infectious complications in paediatric patients treated with extracorporeal membrane oxygenation [J]. Enferm Infecc Microbiol Clin (Engl Ed), 2018, 36(9): 563-567.
27	Butler DF, Lee B, Molitor-Kirsch E, et al. Extracorporeal membrane oxygenation-associated bloodstream infections in children [J]. Pediatr Infect Dis J, 2017, 36(3): 346-347.
28	Kaczala GW, Paulus SC, Al-Dajani N, et al. Bloodstream infections in pediatric ECLS: usefulness of daily blood culture monitoring and predictive value of biological markers. The British Columbia experience [J]. Pediatr Surg Int, 2009, 25(2): 169-173.
29	Kutlesa M, Santini M, Krajinović V, et al. Nosocomial blood stream infections in patients treated with venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome [J]. Minerva Anestesiol, 2017, 83(5): 493-501.
30	Na SJ, Chung CR, Choi HJ, et al. Blood stream infection in patients on venovenous extracorporeal membrane oxygenation for respiratory failure [J]. Infect Control Hosp Epidemiol, 2018, 39(7): 871-874.
31	Wang JR, Huang JY, Hu W, et al. Bloodstream infections in patients undergoing extracorporeal membrane oxygenation [J]. Pak J Med Sci, 2020, 36(6): 1171-1176.
32	Menaker J, Galvagno S, Rabinowitz R, et al. Epidemiology of blood stream infection in adult extracorporeal membrane oxygenation patients: a cohort study [J]. Heart Lung, 2019, 48(3): 236-239.
33	Conrick-Martin I, O'Gorman J, Lenehan D, et al. Nosocomial infections in a cohort of extracorporeal life support patients [J]. Crit Care Resusc, 2012, 14(3): 198-201.
34	Grasselli G, Scaravilli V, Di Bella S, et al. Nosocomial infections during extracorporeal membrane oxygenation: incidence, etiology, and impact on patients' outcome [J]. Crit Care Med, 2017, 45(10): 1726-1733.
35	Bougle A, Bombled C, Margetis D, et al. Ventilator-associated pneumonia in patients assisted by veno-arterial extracorporeal membrane oxygenation support: epidemiology and risk factors of treatment failure [J]. PLoS One, 2018, 13(4): e0194976.
36	Allou N, Lo Pinto H, Persichini R, et al. Cannula-related infection in patients supported by peripheral ECMO: clinical and microbiological characteristics [J]. ASAIO J, 2019, 65(2): 180-186.
37	Schutze GE, Heulitt MJ. Infections during extracorporeal life support [J]. J Pediatr Surg 1995, 30(6): 809-812.
38	Pluim T, Halasa N, Phillips SE, et al. The morbidity and mortality of patients with fungal infections before and during extracorporeal membrane oxygenation support [J]. Pediatr Crit Care Med, 2012, 13(5): e288-293.
39	Cavayas YA, Yusuff H, Porter R. Fungal infections in adult patients on extracorporeal life support [J]. Crit Care, 2018, 22(1): 98.
40	Coffin SE, Bell LM, Manning M, et al. Nosocomial infections in neonates receiving extracorporeal membrane oxygenation [J]. Infect Control Hosp Epidemiol 1997, 18(2): 93-96.
41	Brown KL, Ridout DA, Shaw M, et al. Healthcare-associated infection in pediatric patients on extracorporeal life support: the role of multidisciplinary surveillance [J]. Pediatr Crit Care Med, 2006, 7(6): 546-550.
42	Silvetti S, Ranucci M, Pistuddi V, et al. Bloodstream infections during post-cardiotomy extracorporeal membrane oxygenation: Incidence, risk factors, and outcomes [J]. Int J Artif Organs, 2019, 42(6): 299-306.
43	Rodriguez-Goncer I, Thomas S, Foden P, et al. Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation [J]. Eur J Clin Microbiol Infect Dis, 2018, 37(7): 1251-1257.
44	Gardner AH, Prodhan P, Stovall SH, et al. Fungal infections and antifungal prophylaxis in pediatric cardiac extracorporeal life support [J]. J Thorac Cardiovasc Surg, 2012, 143(3): 689-695.
45	Extracorporeal Life Support Organization (ELSO). ELSO Task Force on Infectious Disease on ECMO: diagnosis, treatment and prevention [EB/OL]. Ann Arbor, MI: ELSO. (2012) [2017-05-12] URL
46	O'Horo JC, Cawcutt KA, De Moraes AG, et al. The evidence base for prophylactic antibiotics in patients receiving extracorporeal membrane oxygenation [J]. ASAIO J, 2016, 62(1): 6-10.
47	Corley A, Lye I, Lavana JD, et al. Nosocomial infection prevalence in patients undergoing extracorporeal membrane oxygenation (ECMO): protocol for a point prevalence study across Australia and New Zealand [J]. BMJ Open, 2019, 9(7): e029293.

[1]	农云洁, 黄小桂, 黄裕兰, 农恒荣. 超声在多重肺部感染诊断中的临床应用价值[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(09): 872-876.
[2]	李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[3]	刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[4]	赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[5]	李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[6]	常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[7]	徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[8]	王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[9]	刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[10]	嵇振岭, 陈杰, 唐健雄. 重视复杂腹壁疝手术并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 601-606.
[11]	江志鹏, 钟克力, 陈双. 复杂腹壁疝手术后腹腔高压与腹腔间室综合征的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 612-615.
[12]	王学虎, 赵渝. 复杂腹壁疝手术中血管损伤并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 616-619.
[13]	皮尔地瓦斯·麦麦提玉素甫, 李慧灵, 艾克拜尔·艾力, 李赞林, 王志, 克力木·阿不都热依木. 生物补片修补巨大复发性腹壁切口疝临床疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 624-628.
[14]	贾玲玲, 滕飞, 常键, 黄福, 刘剑萍. 心肺康复在各种疾病中应用的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 859-862.
[15]	颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Research progress in hospital acquired infections of ECMO patients

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Research progress in hospital acquired infections of ECMO patients